report
APAC’s HTA adoption to grow amidst infrastructure, talent challenges
APAC’s HTA adoption to grow amidst infrastructure, talent challenges
Key markets include Indonesia, the Philippines, and Australia.
2 days ago
Oral proteins and peptides market to hit $24b by 2030
Its expansion is attributed to the prevalence of chronic diseases like diabetes.
2 days ago
Physicians divided over patient choice in biologics vs biosimilars
China’s physicians expressed the highest support amongst surveyed countries.
2 days ago
Global cardiac monitoring market to be valued at $13.24b by 2030
By end user, the hospital segment accounts for the largest market share.
2 days ago
Smart hospitals market to surpass $161.6b by 2033
Thanks to healthcare automation, AI, and IoT-based medical devices.
3 days ago
7MM COPD market to hit $30.2b in 2033
Triple therapy inhalers are expected to account for 11.3% of the total market.
4 days ago
What drives the shoulder arthroplasty field?
Improved fixation techniques are helping prevent failures and reduce repeat surgeries.
4 days ago
What to expect with APAC’s elder care products market?
The global market is expected to reach $45b by the end of 2032.
4 days ago
Australia’s PET imaging agents market to see 2% CAGR growth until 2033
The sector’s expansion is driven by a surge in prostate cancer cases.
4 days ago
Singapore’s oncology landscape to advance with histotripsy technology
The approach is an ultrasound-based technique that offers a pain-free alternative.
4 days ago
Global injectible drug delivery devices market to hit $317.2b by 2029
Biologic drug development is driving the demand for advanced injectable delivery systems.
6 days ago
China’s mechanical heart valves market to reach $50m in 2033
The country accounts for about 50% of the market share in the Asia Pacific.
6 days ago
7MM regulatory T-cell market to grow over 57% CAGR by 2034
Currently, no Treg-based therapies are approved.
India's healthcare expenditure to rise to 5% of GDP by 2030
The growth is driven by structural improvements within the sector.
What can we expect from Turkiye’s health sector?
Persistent economic instability remains a key constraint.
Cytogenetics market to be valued at $5.5b by 2031
Its growth is attributed to the rising prevalence of genetic disorders and cancer.
Healthcare payers lag in digital maturity: report
AI solutions could cut costs and increase revenue for payers.
Most Read
1. Fortis Healthcare unveils new institute for genomic medicine in India 2. Singapore’s oncology landscape to advance with histotripsy technology 3. New photon-counting CT scanner unveiled at Sengkang General Hospital 4. Mount Elizabeth Hospital rolls out WebApp with AI, AR features 5. Vinayaka Missions Super Speciality Hospital opens in Puducherry, IndiaResource Center
Read Here
Advertise
Sign Up
Partner Events
Event News
It has intentionally priced itself at the affordable market segment to provide best-in-class lab testing to as many Filipinos as possible.
